RxDoctor Payments Data

Christianne Curbow

Family · Oxford, MSNPI 1902146624

Payments from drug & device makers

$1,241in general payments, 2019–2025

Across 68 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$317
  • Collegium Pharmaceutical, Inc.$186
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$184
  • Boston Scientific$135
  • Nalu Medical, Inc.$99
  • Indivior Inc.$60
  • plus $260 from 9 others

What the payments were for

  • Food & beverage$1,241100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,241 in reported general payments places this provider in the 70th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$69,757
Medicare patients
268
Services billed
1,067

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate32$32,563
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen368$8,608
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen302$8,054
ZtlidoLidocaine13$6,082
Oxycodone Hcl185$3,483
Gabapentin297$3,189
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl15$1,739
Morphine Sulfate ErMorphine Sulfate67$1,587
Tramadol Hcl ErTramadol Hcl24$1,501
Pregabalin107$1,293
Cyclobenzaprine Hcl100$883
Lidocaine11$859
Tizanidine Hcl157$846
Tramadol Hcl94$759
Fentanyl15$720

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$186$32,56332 claims
Scilex Pharmaceuticals Inc.Ztlido$317$6,08213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,007 family providers in Mississippi.

Other family in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →